Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapy

Supportive Care in Cancer

Volumn 19, Issue 12, 2011, Pages 2063-2066

  Hesketh, Paul J ^a   Bosnjak, Snezana M ^b   Nikolic, Vlada ^b   Rapoport, Bernardo ^c  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^c Medical Oncology Centre of Rosebank   (South Africa)

Author keywords

Colorectal cancer; Irinotecan; Nausea; Vomiting

Indexed keywords

BEVACIZUMAB; CETUXIMAB; DEXAMETHASONE; DOLASETRON MESILATE; FLUOROURACIL; FOLINIC ACID; GRANISETRON; HISTAMINE H3 RECEPTOR ANTAGONIST; IRINOTECAN; ONDANSETRON;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; FEMALE; HUMAN; INCIDENCE; MALE; MEDICAL RECORD; NAUSEA AND VOMITING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; COLORECTAL NEOPLASMS; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NAUSEA; PROSPECTIVE STUDIES; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; VOMITING;

EID: 83555172573     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-011-1286-6     Document Type: Article

References (10)

1. PJ Hesketh 2008 Chemotherapy-induced nausea and vomiting N Engl J Med 358 23 2482 2494 18525044 10.1056/NEJMra0706547 1:CAS:528:DC%2BD1cXmvFKltL0%3D (Pubitemid 351793021)
2. PJ Hesketh MG Kris SM Grunberg, et al. 1997 Proposal for classifying the acute emetogenicity of cancer chemotherapy J Clin Oncol 15 103 9 8996130 1:STN:280:DyaK2s7kvFehsA%3D%3D (Pubitemid 27020563)
3. MG Kris PJ Hesketh MR Somerfield, et al. 2006 American Society of Clinical Oncology. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006 J Clin Oncol 24 18 2932 2947 16717289 10.1200/JCO.2006.06.9591 1:CAS:528:DC%2BD28XntV2gs7k%3D (Pubitemid 46630595)
4. F Roila J Herrstedt M Aapro, et al. 2010 Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference Ann Oncol 21 Suppl 5 v232 43 20555089 10.1093/annonc/mdq194
5. R Tavorath PJ Hesketh 1996 Drug treatment of chemotherapy-induced delayed emesis Drugs 52 5 639 648 9118814 10.2165/00003495-199652050-00002 1:CAS:528:DyaK28XntF2qurg%3D (Pubitemid 26382184)
6. MG Kris RJ Gralla RA Clark, et al. 1985 Incidence, course and severity of delayed nausea and vomiting following the administration of high-dose cisplatin J Clin Oncol 3 1379 84 4045527 1:STN:280:DyaL28%2FhtVCltw%3D%3D (Pubitemid 15244935)
7. M Martin E Diaz-Rubio A Sanchez, et al. 1990 The natural course of emesis after carboplatin treatment Acta Oncologica 29 593 595 2206572 10.3109/02841869009090058 1:STN:280:DyaK3M%2FgtVOguw%3D%3D (Pubitemid 20294735)
8. Hesketh PJ, Sanz-Altamira P, Bushey J, Hesketh AM (2011) Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy. Support Care Cancer (Epub ahead of print) May 9, 2011
9. M Fukuoka H Niitani A Suzuki, et al. 1992 A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer J Clin Oncol 10 16 20 1309380 1:STN:280:DyaK38%2Fpt1Smug%3D%3D
10. Y Shimada M Yoshino A Wakui, et al. 1993 Phase II study of CPT-11, a new camptothecin derivative in metastatic colorectal cancer J Clin Oncol 11 909 13 8487053 1:STN:280:DyaK3s3ltlCgtw%3D%3D (Pubitemid 23146086)